Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM ANHYDROUS vs MESNA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM ANHYDROUS vs MESNA: Safety Overview

Metric MEROPENEM ANHYDROUS MESNA
Total FAERS Reports 144 4,892
Deaths Reported 25 1,029
Death Rate 17.4% 21.0%
Hospitalizations 102 2,155
Average Patient Age 55.0 yrs 39.3 yrs
% Female Patients 44.2% 46.8%
FDA Approval Date N/A Apr 13, 2010
Manufacturer Mylan Institutional LLC Hikma Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Prescription